What is the imaging modality of choice for diagnosing and monitoring brain tumors?

Prepare for the American Board of Professional Psychology (ABPP) Exam with flashcards and multiple-choice questions. Each question includes insights and explanations to help you excel. Get ready for your certification journey!

Multiple Choice

What is the imaging modality of choice for diagnosing and monitoring brain tumors?

Contrast-enhanced MRI provides the most sensitive and specific information for diagnosing and monitoring brain tumors. The gadolinium-based contrast highlights areas where the blood–brain barrier is disrupted and where tumor vessels are abnormal, making tumor margins, surrounding edema, and interior features more clearly delineated. This helps determine the full extent of the tumor, assess grade-related characteristics, and distinguish tumor tissue from treatment effects such as scar or necrosis. Beyond a single image, MRI offers multiple sequences (such as T1 with contrast, T2, FLAIR, diffusion, and sometimes perfusion) that together give a comprehensive picture of cellularity, edema, necrosis, and vascularity. Because patients often require repeated imaging to track response to therapy or progression, MRI is favored for serial exams due to the lack of ionizing radiation and the ability to use the same imaging protocol over time for consistent comparisons. CT can quickly show certain acute issues and is useful if MRI is not available or contraindicated, but it has lower soft tissue contrast for brain tumors and relies on radiation exposure. MRI without contrast cannot reveal enhancement patterns critical for identifying tumor activity. PET adds metabolic information and is adjunctive in specific situations but does not replace the anatomical detail and repeatable monitoring capability of contrast-enhanced MRI.

Contrast-enhanced MRI provides the most sensitive and specific information for diagnosing and monitoring brain tumors. The gadolinium-based contrast highlights areas where the blood–brain barrier is disrupted and where tumor vessels are abnormal, making tumor margins, surrounding edema, and interior features more clearly delineated. This helps determine the full extent of the tumor, assess grade-related characteristics, and distinguish tumor tissue from treatment effects such as scar or necrosis.

Beyond a single image, MRI offers multiple sequences (such as T1 with contrast, T2, FLAIR, diffusion, and sometimes perfusion) that together give a comprehensive picture of cellularity, edema, necrosis, and vascularity. Because patients often require repeated imaging to track response to therapy or progression, MRI is favored for serial exams due to the lack of ionizing radiation and the ability to use the same imaging protocol over time for consistent comparisons.

CT can quickly show certain acute issues and is useful if MRI is not available or contraindicated, but it has lower soft tissue contrast for brain tumors and relies on radiation exposure. MRI without contrast cannot reveal enhancement patterns critical for identifying tumor activity. PET adds metabolic information and is adjunctive in specific situations but does not replace the anatomical detail and repeatable monitoring capability of contrast-enhanced MRI.

More practice questions